FULBAT MSDS - GEL Battery

Page 1


VRLA-Sealed&NonSpillablebattery

AccordingtoRegulation(EU)No2020/878 AccordingtoRegulation(EC)No1272/2008

Version4.0

Section1Identificationofthesubstance/mixtureandofthecompany/undertaking

1.1Productidentifier:

ProductForm: Article

Productname: VRLA-Sealed&NonSpillablebattery

Productcode: GEL/SLAbattery

UFIcode: N/A

1.2Relevantidentifiedusesofthesubstanceandusesadvisedagainst:

1.2.1Identifieduses: MotorcycleandPowersportstarterbattery.

1.2.2Usesadvisedagainst: Notavailable.

1.3Detailsofthesupplierofthesafetydatasheet:

Supplier: FULBATSAS

Address: 30RuePasteur 92150Suresnes

France

Telephone: (France)+33183624555

1.4EmergencytelephoneNumber:

CHEMTREC(US,Canada&Mexico)0086-1-800-424-9300

CHEMTREC(International)0086-1-703-527-3887

Availableoutsideofficehours?YES

Section2HazardsIdentification

2.1Classificationofthesubstance/mixture:

2.1.1Classification: ThemixtureisclassifiedasfollowingaccordingtoREGULATION(EC)No1272/2008: : Harmfulifswallowed. H302 Harmfulifinhaled. H332 Skincorrosion/irritationCategory1A H314 Causesseriouseyedamage. H318 Reproductivetoxicity,Category1A H360Fd Maycauseharmtobreast-fedchildren H362 Specifictargetorgantoxicity(repeatedexposure)Category1AH372 Hazardoustotheaquaticenvironment-AcuteHazard,Category1H400 Hazardoustotheaquaticenvironment-ChronicHazard,Category1H410 Fulltextofhazardclasses,H-andEUH-statements:seesection16

Productname:VRLA–Sealed&NonSpillablebattery

Issuedate:02/12/2019

Revisiondate:18/04/2023

1/18 Version#:4.0 Revisiondate:18/04/2023.

Nohazardsincaseofanintactbatteryandusingaccordingtheinstructions.Thebatteryshouldnotbeopenedorburned.Exposuretothe ingredientscontainedwithinortheircombustionproductscouldbeharmful.

2.2labelelements:

HazardPictograms:

SignalWord(S): Danger

HazardStatement:

Precautionarystatement:

2.3Otherhazards:

H302+H332-Harmfulifswallowedorifinhaled.

H314-Causessevereskinburnsandeyedamage H360Fd-Maydamagefertility.Suspectedofdamagingtheunbornchild H362-Maycauseharmtobreast-fedchildren

H372-Causesdamagetoorgansthroughprolongedorrepeatedexposure H410-Verytoxictoaquaticlifewithlonglastingeffects

P201-Obtainspecialinstructionsbeforeuse

P202-Donothandleuntilallsafetyprecautionshavebeenreadandunderstood P273-Avoidreleasetotheenvironment

P280-Wearprotectivegloves/protectiveclothing/eyeprotection/faceprotection/hearing protection.

P301+P330+P331:IFSWALLOWED:Rinsemouth.DoNOTinducevomiting.

P303+P361+P353:IFONSKIN(orhair):Takeoffimmediatelyallcontaminated clothing.Rinseskinwithwater/shower.

P304+P340:IFINHALED:Removepersontofreshairandkeepcomfortablefor breathing.

P305+P351+P338:IFINEYES:Rinsecautiouslywithwaterforseveralminutes. Removecontactlenses,ifpresentandeasytodo.Continuerinsing

Otherhazardswhichdonotresultinclassification:Leadmaybetoxictoblood,kidneys,centralnervoussystem. Thissubstance/mixturedoesnotmeetthePBTcriteriaofREACHregulation,annexXIII Thissubstance/mixturedoesnotmeetthevPvBcriteriaofREACHregulation,annexXIII ContainsnoendocrinedisruptorandPBT/vPvBsubstances≥0.1%assessedinaccordancewithREACHAnnexXIII

Productname:VRLA–Sealed&NonSpillablebattery

2/18 Version#:4.0

Revisiondate:18/04/2023.

Section3Composition/informationoningredients

Substance/Mixture: Mixture

Ingredient(s):

Name Productidentifier

Lead (CASNo)7439-92-1 (ECno)231-100-4

Leaddioxide

SulfuricAcid

Tin

Calcium

Aluminium

CAS-No.:1309-60-0 ECNo.:215-174-5

CAS-No.:7664-93-9 ECNo.:231-639-5

CAS-No.:7440-31-5 ECNo.:231-141-8

CAS-No.:7440-70-2 ECNo.:231-179-5

CAS-No.:7429-90-5 ECNo.:231-072-3

Name Productidentifier

Lead (CASNo):7439-92-1 (ECno):231-100-4 (REACHno):01-2119458838-20

SulfuricAcid

CAS-No.:7664-93-9 ECNo.:231-639-5

Productname:VRLA–Sealed&NonSpillablebattery

Version#:4.0

Concentration%Classificationaccordingto Regulation(EC)No. 1272/2008[CLP]

56-63%Repr.1A,H360 STOTRE1,H372

AquaticAcute1H400(M=10) AquaticChronic1,H410(M=10)

27-37%AcuteTox.4(Oral),H302 (ATE=500mg/kgbodyweight) AcuteTox.4(Inhalation:vapour), H332Repr.1A,H360STOTRE 2,H373AquaticAcute1,H400

20-27%SkinCorr.1A,H314

0.10-0.25%Notclassified

0.04-0.11%H261

≤0.04%H261 H228

Specificconcentrationlimits

(0.03≤C≤100)Repr.1A,H360D

(5≤C<15)EyeIrrit.2,H319 (5≤C<15)SkinIrrit.2,H315 (15≤C≤100)SkinCorr.1A,H314

Revisiondate:18/04/2023.

Section4Firstaidmeasures

4.1Descriptionoffirstaidmeasures: Inallcasesofdoubt,orwhensymptomspersist,seekmedicalattention.

4.1.1Incaseofinhalation:

SulfuricAcid:Removetofreshairimmediately.Ifbreathingisdifficult,giveoxygen.LeadCompounds:Removefromexposure, gargle,washnoseandlips,consultphysician.

4.1.2Incaseofskincontact:

SulfuricAcid:Flushwithlargeamountsofwaterforatleast15minutes,removeanycontaminatedclothing.Ifirritation developsseekmedicalattention.LeadCompounds:Washwithsoapandwater.

4.1.3Incaseofeyescontact:

SulfuricAcid:Flushimmediatelywithwaterfor15minutes,consultaphysician.LeadCompounds:Flushimmediatelywith waterfor15minutes,consultaphysician.

4.1.4Incaseofingestion:

SulfuricAcid:Donotinducevomiting,consultaphysicianimmediately.LeadCompounds:Consultaphysicianimmediately.

4.2Mostimportantsymptomsandeffects,bothacuteanddelayed:

Causessevereskinburnsandeyedamage.Maydamagefertility.Maydamagetheunbornchild.Maycauseharmtobreast-fedchildren.

AcuteHealthHazards:SulfuricAcid:Severeskinirritation,burns,damagetocorneamaycauseblindness,upperrespiratory irritation.LeadCompounds:Maycauseabdominalpain,nausea,headaches,vomiting,lossofappetite,severecramping,muscular achesandweakness,anddifficultysleeping.Thetoxiceffectsofleadarecumulativeandslowtoappear.Itaffectsthekidneys, reproductiveandcentralnervoussystems.Thesymptomsofleadoverexposurearelistedabove.Exposuretoleadfromabatterymost oftenoccursduringleadreclamationoperationsthroughthebreathingoringestionofleaddustorfumes.

ChronicHealthHazards:Sulfuricacid:Possiblescarringofthecornea,inflammationofthenose,throatandbronchialtubes, possibleerosionoftoothenamel.LeadCompounds:Maycauseanemia,damagetokidneysandnervoussystem,anddamageto reproductivesysteminbothmalesandfemales.

MedicalConditionsGenerallyAggravatedbyExposure:Inorganicleadanditscompoundscanaggravatechronicformsofkidney,liver, andneurologicaldiseases.Contactofbatteryelectrolyte(acid)withtheskinmayaggravateskindiseasessuchaseczemaandcontact dermatitis.Overexposuretosulfuricacidmistmaycauselungdamageandaggravatepulmonaryconditions.

4.3Indicationofanyimmediatemedicalattentionandspecialtreatmentneeded: Nofurtherrelevantinformationavailable.

Section5Fire-Fightingmeasures

5.1Extinguishingmedia:

Suitableextinguishingmedia: Useextinguishingmediaappropriateforsurroundingfire-lfabatteryruptures,usedry chemical,sodaash,lime,sandorcarbondioxide.

Unsuitableextinguishingmedia:NoneKnown.

5.2SpecialhazardsarisingfromtheSealedbatteriescanemithydrogenonlyifovercharged(floatvoltage>2.41VPC). substanceormixture Thegasenterstheairthroughtheventcaps.ToABS:Temperaturesover300°C

5.3Adviceforfirefighters:

Section6Accidentalreleasemeasures

GeneralMeasures:

6.1.1Fornon-emergencypersonnel:

6.1.2Foremergencyresponders:

(572°F)mayreleasecombustiblegases.ToPP:Temperaturesover380°C(716°F) mayreleasecombustiblegases.

Leadcompoundsandsulfuricacidfumemaybereleasedduringafireinvolvingthe product.Batterymayruptureduetopressurebuildupwhenexposedtoexcessive heatandmayberesultinthereleaseofcorrosivematerials.

Mayreactwithcombustiblesubstancescreatingfireorexplosionhazard.Reacts violentlywithwater.Reactsviolentlywithoxidizingsubstances.Reactswithmost metalstoproducehydrogengas,lvhichcanformanexplosivemixturewithair.

Wearpositivepressureself-containedbreathingapparatus.Wearfullyprotective suit.

Avoidcontactwithspilledmaterial.Donottouchdamagedcontainersorspilled materialunlesswearingappropriateprotectiveequipment.

UseproperpersonalprotectiveequipmentasindicatedinSection8.Ensureadequate ventilation.Avoidcontactwitheyes.Wearprotectiveequipment.Keepunprotected personsaway.

Wearpositivepressureself-containedbreathingapparatusifdustisgenerated.

Donotallowproducttoreachsewagesystemoranywatercourse.Inform respectiveauthoritiesincaseofseepageintowatercourseorsewagesystem.Do notallowtoentersewers/surfaceorgroundwater.

Incasethereleaseoccurs,stopflowofmaterial:contain/absorbsmallspillswithdry sand,earth,andvermiculite.Ifpossible,carefullyneutralizespilledelectrolytewithsoda ash,sodiumbicarbonate,lime,etc.Wearacid-resistantclothing,boots,gloves,and faceshield.Donotallowdischargeofunneutralizedacidtosewer.SpentBatteriessendtosecondaryleadsmelterforrecycling.Followapplicablefederal,stateandlocal regulationsNeutralizeasinprecedingstep.Collectneutralizedmaterialinsealed containerandhandleashazardouswasteasapplicable. 6.4Referencetoothersections:

SeeSection7forinformationonsafehandling.

SeeSection8forinformationonpersonalprotectionequipment.

SeeSection13forinformationondisposal.

Productname:VRLA–Sealed&NonSpillablebattery

5/18 Version#:4.0 Revisiondate:18/04/2023.

Section7Handlingandstorage

7.1Precautionsforsafehandling:

7.1.1Protectivemeasures:

7.1.2Adviceongeneraloccupational

Ensuregoodventilation/exhaustionattheworkplace.Avoidcontactwitheyes.Keep ignitionsourcesaway-Donotsmoke.Duetothebattery’slowinternalresistanceand highpowerdensity,highlevelsofshortcircuitcurrentcanbedevelopedacrossthe batteryterminals.Donotresttoolsorcablesonthebattery.Useinsulatedtoolsonly. Followallinstallationinstructionsanddiagramswheninstallingormaintainingbattery systems.

Donoteat,drinkandsmokeinworkareas.Washhandsafteruse.Remove hygiene: contaminatedclothingandprotectiveequipmentbeforeenteringeatingareas.

7.2Conditionsforsafestorage,including anyincompatibilities:

Storebatteriesinacool,dry,wellventilatedareathatareseparatedfromincompatible materialsandanyactivitieswhichmaygenerateflames,sparks,orheat.Keepaway fromallmetallicarticlesthatcouldcontactthenegativeandpositiveterminalsona batteryandcreateashortcircuitcondition.Batteryshouldbestoredunderrooffor protectionagainstadverseweatherconditions.Storeandhandleonlyinareaswith adequatewatersupplyandspillcontrol.Avoiddamagetobatterycase.

7.3Specificenduse(s): Notapplicable.

Section8ExposureControls/PersonalProtection

8.1Controlparameters:

Lead(7439-92-1)

EUEuropeanBEI

AustriaMAK(mg/m3)

(Medium:blood-Time:norestriction-Parameter:

Lead(bindingbiologicallimitvalue)

0.075mg/m3(Medium:air-Time:40hoursperweek Parameter:Lead(TWAmedicalsurveillancethresholdinair measuredasatimeweightedaverageover40hoursperweek)

(Medium:blood-Time:norestriction–Parameter:Lead (medicalsurveillancethresholdmeasuredinindividualworkers)

0.1mg/m3(inhalablefraction)

AustriaMAKShorttimevalue(mg/m3)0.4mg/m3(inhalablefraction)

BulgariaOELTWA(mg/m3)

BulgariaBulgaria-BEI

Lead(7439-92-1)

0.05mg/m3

300µg/l(Medium:blood-Time:notlixed-Parameter:Lead (forwomenunder45yearsold)

400µg/l(Medium:blood-Time:notfixed-Parameter:Lead)

CroatiaGVI(graniënavrijednostizloZenosti)(mg/m3)0.15mg/m3

Productname:VRLA–Sealed&NonSpillablebattery

6/18 Version#:4.0 Revisiondate:18/04/2023.

Lead(7439-92-1)

CroatiaCroatia-BEI

CyprusOELTWA(mg/m3)

(Medium:blood-Time:notcritical-Parameter:Lead(Medical surveillanceshouldbecarriedoutlvhenthelimitvalueofLead inbloodofworkers>40µg/100mLblood)

(Medium:urine-Time:singlesampleorurinecollectedover 24hours-Parameter:Lead(Forallresultsthatareexpressed onCreatinine,Creatinineconcentration<0.5g/Land>3.0g/L shouldnotbeconsidered)

(Medium:blood-Time:notcritical-Parameter: delta.Aminolevulinicaciddehydratase)

(Medium:blood-Time:afterexposureduring2-3months(light protectedsample)-Parameter:

Protoporphyrininerythrocytes(lnterferenceoflrondeficiency (anemiasideropenic))

0.15mg/m3

CzechRepublicExpoziënilimity(PEL)(mg/m3)0.05mg/m3

(Medium:urine-Time:discretionary-Parameter:5 Aminolevulinicacid(Forshorttermcontinualexposures<=30 calendardays)

(Medium:urine-Time:discretionary-Parameter: Coproporphyrin(Forshorttermcontinualexposures<=30 calendardays)

CzechRepublicCzechRepublic-BEI

(Medium:urine-Time:discretionary-Parameter:5 Aminolevulinicacid(Forshorttermcontinualexposures<=30 calendardays)

(Medium:urine-Time:discretionary-Parameter: Coproporphyrin(Forshorttermcontinualexposures<=30 calendardays)

0.4mg/l(Medium:blood-Time:discretionary-Parameter: Lead)

DenmarkGrænseværdie(langvarig)(mg/m3)0.05mg/m3(dust,fumeandpowder)

DenmarkDenmark-BEI

EstoniaOELTWA(mg/m3)

FinlandHTP-arvo(8h)(mg/m3)

FinlandFinland-BEI

FranceVME(mg/m3)

FranceFrance-BEI

(Medium:blood-Parameter:Lead)

0.1mg/m3(totaldust)

0.05mg/m3(respirabledust)

0.1mg/m3(allworks)

(Medium:blood-Time:notcritical-Parameter:Lead)

0.1mg/m3(restrictivelimit)

400µg/l(Medium:blood-Parameter:Lead(biologicallimit value,men)

300µg/l(Medium:blood-Parameter:Lead(biologicallimit value,women)

200µg/l(Medium:blood-Parameter:Lead(medical surveillancevalue,men)

100µg/l(Medium:blood-Parameter:Lead(medical surveillancevalue,women)

Productname:VRLA–Sealed&NonSpillablebattery

7/18 Version#:4.0 Revisiondate:18/04/2023.

Lead(7439-92-1)

GermanyTRGS903(BGW)

GibraltarOELTWA(mg/m3)

GibraltarGibraltar-BEI

GreeceOELTWA(mg/m3)

HungaryAK-érték

lrelandOEL(8hoursref)(mg/m3)

lrelandOEL(15minref)(mg/m3)

ItalyOELTWA(mg/m3)

ItalyItaly-BEI

LatviaOELTWA(mg/m3)

LatviaLatvia-BEI

LithuaniaIPRV(mg/m3)

LuxembourgOELTWA(mg/m3)

LuxembourgLuxembourg-BEI

PolandNDS(mg/m3)

Productname:VRLA–Sealed&NonSpillablebattery

Revisiondate:18/04/2023.

300µg/l(Medium:wholeblood-Time:norestriction Parameter:Lead(womenagebelow45years)

400µg/l(Medium:wholeblood-Time:norestriction Parameter:Lead(women45yearsandolder)

0.15mg/m3

(Medium:blood-Time:norestriction-Parameter:Lead(binding biologicallimitvalue)

0.075mg/m3(Medium:air-Time:40hoursperweek Parameter:Lead(medicalsurveillancethresholdmeasuredin individualemployees)

(Medium:blood-Time:norestriction-Parameter:Lead(medical surveillancethresholdmeasuredinindividualemployees)

0.15mg/m3

0.15mg/m3

0.15mg/m3

0.45mg/m3(calculated)

0.075mg/m3

(Medium:blood-Time:endofworkweek(Leadremediationmust beperformedwhenuorkersoffertileagehaveLeadinblood levels>40µg/100mL)

0.005mg/m3

(Medium:blood-Parameter:Lead(referencevalueinbloodfor occupationallyunexposedpopulation<=10µg/100mL)

(Medium:urine-Parameter:Coproporphyrin(referencevalue 22-57µg/gCreatinine)

(Medium:urine-Parameter:Aminolevulinicacid(reference value0.5-2.5mg/gCreatinine)

0.15mg/m3(inhalablefraction)

0.07mg/m3(respirablefraction)

0.15mg/m3

(Medium:blood-Parameter:Lead)0.075mg/m3

(Medium:blood-Parameter:Lead(medicalsurveillance thresholdinairmeasuredasatimeweightedaverageover40 hoursperweek)

(Medium:blood-Parameter:Lead(medicalsurveillance thresholdmeasuredinindividualworkers)

0.05mg/m3

Lead(7439-92-1)

PortugalOELTWA(mg/m3)

RomaniaOELTWA(mg/m3)

RomaniaOELSTEL(mg/m3)

RomaniaRomania-BEI

0.15mg/m3(mandatoryindicativelimitvalue)

0.05mg/m3

0.10mg/m3

150µg/l(Medium:urine-Time:endofshift-Parameter:Lead) (Medium:blood-Time:endofshift-Parameter:Lead)

(Medium:hair-Time:endofshift-Parameter:Lead)10mg/l (Medium:urine-Time:endofshift-Parameter:.delta.Aminolevulinicacid)

300µg/l(Medium:urine-Time:endofshift-Parameter: Coproporphyrin)

(Medium:blood-Time:endofshift-Parameter::Erythrocytes protoporphyrin)

SlovakiaNPHV(priemerna)(mg/m3)0.15mg/m3

400µg/l(Medium:blood-Time:notcritical-Parameter:Lead)

100µg/l(Medium:blood-Time:notcritical-Parameter:Lead (womenyoungerthan45yearsofage)

SlovakiaSlovakia-BEI

SloveniaOELTWA(mg/m3)

SloveniaOELSTEL(mg/m3)

SpainVLA-ED(mg/m3)

15mg/l(Medium:urine-Time:notcritical-Parameter:.delta.Aminolevulinicacid)

6mg/l(Medium:urine-Time:notcritical-Parameter:.delta.Aminolevulinicacid(womenyoungerthan45yearsofage)

0.30mg/l(Medium:urine-Time:nctcriticalParameter: Coproporphyrins)

0.1mg/m3(inhalablefraction)

0.4mg/m3(inhalablefraction)

0.15mg/m3

Spain (Medium:blood-Time:notcritical-Parameter:Lead(3,K)

Swedennivagränsvärde(NVG)(mg/m3)0.1mg/m3(totalinhalabledust)

UnitedKingdomWELTWA(mg/m3)

UnitedKingdomWELSTEL(mg/m3)

0.05mg/m3(totalrespirabledust)

0.15mg/m3

0.45mg/m3(calculated)

NorwayGrenseverdier(AN)(mg/m3)0.05mg/m3(dustandfume)

NorwayGrenseverdier(Korttidsverdi)(mg/m3)0.05mg/m3(dustandfume)

SwitzerlandVME(mg/m3)

SwitzerlandVLE(mg/m3)

SwitzerlandSwitzerland-BEI

Productname:VRLA–Sealed&NonSpillablebattery

0.1mg/m3(inhalabledust)

0.8mg/m3(inhalabledust)

400µg/l(Medium:wholeblood-Time:norestrictionsParameter:Lead (menandwomenover45yearsold)

100µg/l(Medium:wholeblood-Time:norestrictions Parameter:Lead(womenlessthan45yearsold,)

9/18 Version#:4.0

Revisiondate:18/04/2023.

AustraliaTWA(mg/m3)

Canada(Quebec)VEMP(mg/m3)

USA-ACGIHACGIHTWA(mg/m3)

Lead(7439-92-1)

0.15mg/m3(dustandfume)

0.05mg/m3

0.05mg/m3

USA-IDLHUSIDLH(mg/m3 100mg/m3

USA-NIOSHNIOSHREL(TWA)(mg/m3)0.050mg/m3

USA-OSHAOSHAPEL(TWA)(mg/m3)50µg/m3

Sulfuricacid(7664-93-9)

BulgariaOELTWA(mg/m3)

0.05mg/m3(whenchoosingasuitablemethodformonitoring exposureshouldtakeintoaccountpotentialconstraintsand interactionsthatmayoccurinthepresenceofothersulfur compounds-respirableaerosol)

CroatiaGVI(graniČnavrijednostizlozenosti)(mg/m3)0.05mg/m3

CyprusOELTWA(mg/m3)

0.05mg/m3(vapor)

CzechRepublicExpoziČnilimity(PEL)(mg/m3)1mg/m3

0.05mg/m3(concentrated-mist)

DenmarkGrænseværdie(langvarig)(mg/m3)0.05mg/m3(thoracicfraction-mist)

EstoniaOELTWA(mg/m3) 1mg/m3(fume)

FinlandHTP-arvo(8h)(mg/m3)

FinlandHTP-arvo(15min)

FranceVME(mg/m3)

0.05mg/m3

0.1mg/m3

0.05mg/m3(thoracicfraction)

FranceVLE(mg/m3) 3mg/m3

GermanyTRGS900Occupationalexposurelimitvalue(mg/m3)

GibraltarOELTWA(mg/m3)

GreeceOELTWA(mg/m3)

0.1mg/m3(Theriskofdamagetotheembryoorfetuscanbe excludedwienAGWandBGWvaluesareobserved-inhalable fraction)

0.05mg/m3(whenselectinganappropriateexposuremonitoring method,accountshouldbetakenofpotentiallimitationsand interferencesthatmayariseinthepresenceofothersulphur compounds-thoracicfraction)

0.05mg/m3(mist)

HungaryAK-érték 0.05mg/m3

lrelandOEL(8hoursref)(ppm) 0.05ppm

lrelandOEL(15minref)(ppm) 0.15ppm(calculated)

Productname:VRLA–Sealed&NonSpillablebattery SDSEU 10/18 Version#:4.0

Revisiondate:18/04/2023.

ItalyOELTWA(mg/m3)

LatviaOELTWA(mg/m3)

LithuaniaIPRV(mg/m3)

LithuanraTPRV(mg/m3)

LuxembourgOELTWA(mg/m3)

MaltaOELTWA(mg/m3)

0.05mg/m3(Whenchoosingasuitablemethodformonitoring exposureshouldtakeintoaccountpotentialconstraintsand interactionsthatmayoccurinthepresenceofothersulfur compounds,respirablefraction-thoracicfraction,mist)

0.05mg/m3(possiblelimitationsandtheimpactthatmayresult fromthepresenceofotherSulfurcomponentsshouldbetakeninto accountwhenchoosinganappropriateexposuremonitoring method-fog,whichisdefinedasthethoracicfraction)

0.05mg/m3(vapor)

3mg/m3(fog-vapor)

0.05mg/m3

0.05mg/m3(mist)

NetherlandsGrenswaardeTGG8H(mg/m3)0.05mg/m3(definedasthoracicfraction-mist)

PolandNDS(mg/m3)

PortugalOELTWA(mg/m3)

RomaniaOELTWA(mg/m3)

SlovakiaNPHV(priemerná)(mg/m3)

SloveniaOELTWA(mg/m3)

SpainVLA-ED(mg/m3)

0.05mg/m3(thoracicfraction)

0.05mg/m3(thoracicfraction-mist)

0.05mg/m3

0.1mg/m3

0.05mg/m3(inhalablefraction,fog)

0.05mg/m3(indicativelimitvalue-mist)

Swedennivågränsvärde(NVG)(mg/m3)0.1mg/m3

Swedenkortidsvärde(KTV)(mg/m3)0.2mg/m3

UnitedKingdomWELTWA(mg/m3)

0.05mg/m3(mist)

NorwayGrenseverdier(AN)(mg/m3)0.1mg/m3(inhalablefraction)

NorwayGrenseverdier(Korttidsverdi)(mg/m3)0.1mg/m5(inhalablefraction)

SwitzerlandVME(mg/m3)

SwitzerlandVLE(mg/m3)

0.1mg/m3(inhalabledust)

0.1mg/m3(inhalabledust)

AustraliaTWA(mg/m3) 1mg/m3

AustraliaSTEL(mg/m3) 3mg/m3

Canada(Quebec;VECD(mg/m3) 3mg/m3

Canada(Quebec)VEMP(mg/m3) 1mg/m3

USA.ACGIHACGIHTWA(mg/m3) 0.2mg/m3(thoracicfraction)

USA–IDLHUSIDLH(mg/m3) 15mg/m3

USA–NIOSHNIOSHREL(TWA)(mg/m3)1mg/m3

USA.OSHAOSHAPEL(TWA)(mg/m3)1mg/m3

Productname:VRLA–Sealed&NonSpillablebattery

11/18 Version#:4.0

Revisiondate:18/04/2023.

8.2Exposurecontrols:

8.2.1Appropriateengineeringcontrols:Handleinaccordancewithgoodindustrialhygieneandsafetypractice.Washhands beforebreaksandattheendofworkday.

8.2.2Individualprotectionmeasures,suchaspersonalprotectiveequipment:

Eye/faceprotection: Noneneededundernormalconditions.Ifbatterycaseisdamaged,usechemical gogglesorfaceshield.

Handprotection: Noneneededundernormalconditions.Ifbatterycaseisdamaged,userubberor plasticacid-resistantgloveswithelbow-lengthgauntlet.

Bodyprotection: Noneneededundernormalconditions.Ifbatterycaseisdamagedwearacid-resistant apron.Undersevereexposureoremergencyconditions,wearacid –resistantclothingandboots.

Respiratoryprotection: Nonerequiredundernormalconditions.Whenconcentrationsofsulfuricacidmist areknowntoexceedPEL,useNIOSHorMSHA-approvedrespiratoryprotection.

Thermalhazards: Wearsuitableprotectiveclothingtopreventheat.

8.2.3Environmentalexposurecontrols:Donotallowproducttoreachsewagesystemoranywatercourse.Informrespective authoritiesincaseofseepageintowatercourseorsewagesystem.Donotallowto entersewers/surfaceorgroundwater.

Section9Physicalandchemicalproperties

9.1Informationonbasicphysicalandchemicalproperties:

Physicalstate: Solid

Colour: Black

Odour: Notavailable

Odourthreshold: Notavailable

pH: Notavailable

Meltingpoint/range(°C): -33.67°C(CAS#7664-93-9)

Boilingpoint/range(°C): Notavailable

Flashpoint(°C): Notavailable

Evaporationrate: Notavailable

Flammabilitylimit-lower(%): Notavailable

Flammability(solid,gas): Notavailable

Ignitiontemperature(°C): Notavailable

Productname:VRLA–Sealed&NonSpillablebattery

12/18 Version#:4.0 Revisiondate:18/04/2023.

Upper/lowerexplosivelimits: Notavailable

Vapourpressure(20°C): 0.485hPa(CAS#7664-93-9)

Vapourdensity: Notavailable

RelativeDensity: 1.81(20°C)(CAS#7664-93-9)

Bulkdensity(kg/m3): Notavailable

Watersolubility(g/l): Notavailable

n-Octanol/Water(logPo/w): Notavailable

Auto-ignitiontemperature: Notavailable

Decompositiontemperature: Notavailable

Viscosity,dynamic(mPa.s): Notavailable

Explosiveproperties: Notavailable

Oxidisingproperties: Notavailable

9.2.Otherinformation:

Fatsolubility(solvent-oiltobespecified) etc: Notavailable

Surfacetension: Notavailable

Dissociationconstantinwater(pKa):Notavailable

Oxidation-reductionPotential: Notavailable

Section10Stabilityandreactivity

10.1Reactivity: Thesubstanceisstableundernormalstorageandhandlingconditions.

10.2Chemicalstability: Stableatroomtemperatureinclosedcontainersundernormalstorageandhandling conditions.

10.3Possibilityofhazardousreactions:Nodangerousreactionsknown.

10.4Conditionstoavoid: Incompatiblematerials.Hightemperature,Sparksandothersourcesofignition. Avoidmixingacidwithotherchemicals.

10.5Incompatiblematerials: Potassium,carbides,sulfides,peroxides,phosphorus,sulfurs,ketone,ester, petrolatum.Reactivemetals,strongbases,mostorganiccompounds.

10.6Hazardousdecompositionproducts:Sealedbatteriescanemithydrogenonlyifovercharged(floatvoltage>2.41VPC). Thegasenterstheairthroughtheventcaps.ToABS:Temperaturesover300°C(572°F) mayreleasecombustiblegases.ToPP:Temperaturesover380°C(716°F)mayrelease combustiblegases.

Section11Toxicologicalinformation

11.1InformationonhazardclassesasdefinedinRegulation(EC)No1272/2008: Acutetoxicity: ATEmix(oral): Harmfulifswallowed

Productname:VRLA–Sealed&NonSpillablebattery

13/18 Version#:4.0 Revisiondate:18/04/2023.

ATEmix(inhalation): Harmfulifinhaled.

ATEmix(Dermal): Notavailable

Sulphuricacid(CAS#7664-93-9)

LD50(Oral,Rat): 2140mg/kg

LC50(Inhalation,Rat): Notavailable

LD50(Dermal,Rabbit): Notavailable

Skincorrosion/Irritation: Causessevereskinburnsandeyedamage.

Seriouseyedamage/irritation: Causesseriouseyedamage.

Respiratoryorskinsensitization: Notclassified

Germcellmutagenicity: Notclassified

Carcinogenicity: Notclassified

Reproductivetoxicity: Notclassified

STOT-singleexposure: Notclassified

STOT-repeatedexposure: Notclassified

Aspirationhazard: Notclassified

11.2Informationonotherhazards

Endocrinedisruptingproperties

Themixturedoesnotcontainendocrinedisruptor.

Otherinformation Notapplicable

Section12Ecologicalinformation

12.1Toxicity:

Lead(CAS:7439-92-1):

AcutetoxicityTimeSpeciesEvaluationRemarks

LC50440µg/L96hFishN/A

Species:Cyprinuscarpio[semi-static])

LC501170µg/L96hFishN/ASpecies:Oncorhynchusmykiss[flow{hroughl)

EC50600µg/L48hDaphniaN/A Species:waterflea

SulfuricAcid(CAS:7664-93-9):

AcutetoxicityTimeSpeciesEvaluationRemarks

LC5082mg/L24hFishN/A Exposuretime:24h-Species:Brachydaniorerio[static]

12.2Persistenceanddegradability:Notavailable.

12.3Bioaccumulativepotential:BCFfish;nobioaccumalion

12.4Mobilityinsoil: Notavailable.

12.5ResultsofPBT&vPvBassessment:Notapplicable

12.6Otheradverseeffects: Notavailable.

Productname:VRLA–Sealed&NonSpillablebattery SDSEU 14/18 Version#:4.0 Revisiondate:18/04/2023.

Section13Disposalconsiderations

13.1Wastetreatmentmethods:

Mustnotbedisposedtogetherwithhouseholdgarbage.Donotallowproductto reachsewagesystem.

Disposeofcontents/containertocomplywithapplicablelocal,nationaland internationalregulations.

Recyclingtheproductisrecommended.Wastemustbedisposedofinaccordance withfederal,stale,andlocalenvironmentalcontrolregulations.

Consulttheappropriatelocalwastedisposalexpertaboutwastedisposal.Since emptiedcontainersretainproductresidue,followlabelwarningsevenaftercontainer isemptied.

Europeenwastecode:160601--leadbatteries

Section14Transportinformation

14.1UNnumberorID number

14.2UNPropershipping name BATTERIES, WET,NONSPILLABLE ELECTRIC STORAGE BATTERIES, WET,NONSPILLABLE ELECTRICSTORAGE

BATTERIES, WET,NONSPILLABLE ELECTRICSTORAGE

BATTERIES, WET,NONSPILLABLE ELECTRICSTORAGE

14.3Transporthazard Class(es) NotregulatedNotregulatedNotregulatedNotregulated 14.4PackinggroupNotregulatedNotregulatedNotregulatedNotregulated

14.5Environmental hazards YesYesYesYes

14.6Specialprecautions foruser SeebelowSeebelowSeebelowSeebelow

14.7Maritimetransportin bulkaccordingtoIMO instruments NotregulatedNotregulatedNotregulatedNotregulated

14.6Specialprecautionsforuser

Landtransport(ADR)

Classificationcode(ADR) :C11

Specialprovisions(ADR) :238,295,598

Limitedquantities(ADR) :1L

Exceptedquantities(ADR) :E0

Packinginstructions(ADR) :P003,P801

Specialpackingprovisions(ADR):PP16

Transportcategory(ADR) :3

Specialprovisionsforcarriage-Bulk(ADR):VV14

Hazardidentificationnumber(KemlerNo.):80 Orangeplates :

Productname:VRLA–Sealed&NonSpillablebattery

15/18 Version#:4.0 Revisiondate:18/04/2023.

Tunnelrestrictioncode(ADR)E EACcode 2R

Seatransport(IMDG)

Specialprovisions(IMDG) :238,295

Limitedquantities(IMDG) :1L

Exceptedquantities(IMDG) :E0

Packinginstructions(IMDG) :P003

Specialpackingprovisions(IMDG):PP16

EmS-No.(Fire :F-A

EmS-No.(Spillage) :S-B

Stowagecategory(IMDG) :A

Propertiesandobservations(IMDG):Metalplatesimmersedingelledalkalineoracidelectrolyteinaglass,hardrubber orplasticsreceptacleofanon-spillabletype.Whenelectricallycharged,maycause firethroughshort-circuitingofterminals.Causeburnstoskin,eyesandmucous membranes.

MFAG-No :154

Airtransport

PCAExceptedquantities(IATA):E0

PCALimitedquantities(IATA):Forbidden PCAlimitedquantitymaxnetquantity(IATA):Forbidden PCApackinginstructions(IATA):872

PCAmaxnetquantity(IATA):Nolimit

CAOpackinginstructions(IATA):872

CAOmaxnetquantity(IATA):Nolimit

Specialprovisions(IATA) :A48,A67,A164,A183

ERGcode(IATA) :8L

Section15Regulationinformation

15.1Safety,healthandenvironmentalregulations/legislationspecificforthesubstanceormixture:

REACHAnnexXVII(RestrictionList):Notapplicable.

REACHAnnexXIV(AuthorisationList):Notapplicable.

REACHCandidateList(SVHC):Containsonesubstance(s)fromthelistofcandidatesubstancesofREACH:Lead(EC231-100-4,CAS 7439-92-1)

OtherNationalregulations:

Noadditionalinformationavailable

15.2ChemicalSafetyAssessment

Noadditionalinformationavailable

Productname:VRLA–Sealed&NonSpillablebattery

16/18 Version#:4.0 Revisiondate:18/04/2023.

Section16Otherinformation

16.1Indicationofchanges: Version4.0Amendedby(EU)2020/878

16.2Abbreviationsandacronyms:

ADR:EuropeanAgreementconcerningtheInternationalCarriageofDangerousGoodsbyRoad

RID:RegulationforrailInternationaltransportationofDangerousgoods

ADN:EuropeanAgreementconcerningtheInternationalCarriageofDangerousGoodsbyInlandWaterways

IMDG:Codeinternationalmaritimedangerousgoodscode

ICAO:InternationalCivilAviationOrganization

IATA:InternationalAirTransportAssociation

UFI:UniqueFormulaIdentifier

LC50:medianlethalconcentration

EC50:Theeffectiveconcentrationofsubstancethatcauses50%ofthemaximumresponse.

NOEC:NoObservedEffectConcentration

DNEL:derivedno-effectlevel

PNEC:predictedno-effectconcentration

16.3Keyliteraturereferencesandsourcesfordata ECHARegisteredsubstancesdata

16.4Traininginstructions: Notapplicable.

16.5Furtherinformation: Thisinformationisbaseduponthepresentstateofourknowledge.ThisSDShasbeencompiledandissolelyintendedforthis product.

16.6Noticetoreader:

Employersshouldusethisinformationonlyasasupplementtootherinformationgatheredbythem,andshouldmakeindependent judgmentofsuitabilityofthisinformationtoensureproperuseandprotectthehealthandsafetyofemployees.

FulltextofH-andEUH-statements:

AcuteTox.4(Inhalation)

AcuteTox.4(Inhalation:dust,mist)

AcuteTox.4(Inhalation:vapour)

AcuteTox.4(Oral)

AquaticAcute1

AquaticChronic1

AquaticChronic3

Acutetoxicity(inhal.),Category4

Acutetoxicity(inhalation:dust,mist)Category4

Acutetoxicity(inhalation:vapour)Category4

Acutetoxicity(oral),Category4

Hazardoustotheaquaticenvironment–AcuteHazard,Category1

Hazardoustotheaquaticenvironment–ChronicHazard,Category1

Hazardoustotheaquaticenvironment–ChronicHazard,Category3

Carc.2 Carcinogenicity,Category2

EyeDam.1

Seriouseyedamage/eyeirritation,Category1

H302 Harmfulifswallowed.

H314

Causessevereskinburnsandeyedamage.

H315 Causesskinirritation

H318

Causesseriouseyedamage.

H319 Causesseriouseyeirritation

H332 Harmfulifinhaled.

H351 Suspectedofcausingcancer.

H360 Maydamagefertilityortheunbornchild.

H360DMaydamagetheunbornchild.

H360FD Maydamagefertility.Maydamagetheunbornchild.

H362 Maycauseharmtobreast-fedchildren.

H372 Causesdamagetoorgansthroughprolongedorrepeatedexposure.

H373 Maycausedamagetoorgansthroughprolongedorrepeated exposure.

H400 Verytoxictoaquaticlife.

H410Verytoxictoaquaticlifewithlonglastingeffects.

H412

Productname:VRLA–Sealed&NonSpillablebattery

Harmfultoaquaticlifewithlonglastingeffects.

17/18 Version#:4.0 Revisiondate:18/04/2023.

Thisinformationisfurnishedwithoutwarranty,andanyuseoftheproductnotinconformancewiththisSafetyDataSheet,orin combinationwithanyotherproductorprocess,istheresponsibilityoftheuser.

Productname:VRLA–Sealed&NonSpillablebattery

Version#:4.0

Revisiondate:18/04/2023.

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.